A Study of ZEN003694 in People With Squamous Cell Lung Cancer

NCT05607108 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Lung Cancer

Interventions

DRUG: ZEN003694

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]